Active MMP-2 effectively identifies the presence of colorectal cancer

International Journal of Cancer

Volumn 125, Issue 12, 2009, Pages 2893-2902

  Murnane, Mary Jo ^a   Cai, Jinguo ^a   Shuja, Sania ^b   McAneny, David ^a   Klepeis, Veronica ^c   Willett, John B ^d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD GRADUATE SCHOOL OF EDUCATION   (United States)

Author keywords

Active MMP 2; Cancer diagnosis; Colorectal carcinomas

Indexed keywords

GELATINASE A; GELATINASE B;

ADULT; AGED; ARTICLE; CANCER STAGING; COLON MUCOSA; COLORECTAL CANCER; COMPUTER AIDED DESIGN; CONTROLLED STUDY; EFFECT SIZE; ENZYME ACTIVITY; EXTRACTION; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RECTUM MUCOSA; STANDARDIZATION; ZYMOGRAPHY;

ADULT; AGED; COLORECTAL NEOPLASMS; ENZYME PRECURSORS; FEMALE; GELATINASES; HUMANS; IMMUNOBLOTTING; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 72449145498     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24682     Document Type: Article

References (47)

1. Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 2000;10:415-433 (Pubitemid 32181912)
2. Vansaun MN, Matrisian LM. Matrix metalloproteinases and cellular motility in development and disease. Birth Defects Res C Embryo Today 2006;78:69-79; Review.
3. Page-Mccaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodeling. Nat Rev Mol Cell Biol 2007;8:221-233 (Pubitemid 46310551)
4. Mook ORF, Frederiks WM, Van Noorden CJF. The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophys Acta 2004;1705:69-89. (Pubitemid 39592897)
5. Björklund M, Koivunen E. Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 2005;1755:37-96. (Pubitemid 40720240)
6. Garbett EA, Reed MWR, Brown NJ. Proteolysis in human breast and colorectal cancer. Br J Cancer 1999;81:287-293 (Pubitemid 29423707)
7. Gimeno-Garcia AZ, Santana-Rodriguez A, Jimenez A, Parro-Blanco A, Nicholas-Perez D, Paz-Cabrera C, Diaz-Gonzalez F, Medina C, Diaz-Flores L, Quintero E. Up-regulation of gelatinases in the colorectal adenoma-carcinoma sequence. Eur J Cancer 2006;42:3146-3252 (Pubitemid 44854506)
8. Koshiba T, Hosotani R, Wada M, Fujimoto K, Lee J-U, Doi R, Arii S, Imamura M. Detection of Matrix Metalloproteinase Activity in Human Pancreatic Cancer. Surg Today Jpn J Surg 1997;27:302-304 (Pubitemid 27164188)
9. Nakamura H, Ueno H, Yamashita K, Shimada T, Yamamoto E, Noguchi M, Fujimoto N, Sato H, Seiki M, Okada Y. Enhanced Production and Activation of Progelatinase A Mediated by Membrane-Type 1 Matrix Metalloproteinase in Human Papillary Thyroid Carcinomas. Cancer Res 1999;59:467-473 (Pubitemid 29048885)
10. Nomura H, Fujimoto N, Seiki M, Mai M, Okada Y. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas. Int J Cancer (Pred Oncol) 1996;69:9-16. (Pubitemid 26083264)
11. Patel BP, Shah SV, Shukla SN, Shah PM, Patel PS. Clinical significance of MMP-2 and MMP-9 in patients with oral cancer. Head Neck 2007;29:564-572 (Pubitemid 47324773)
12. Sheu B-C, Lien H-C, Ho H-N, Lin H-H, Chow S-N, Huang S-C, Hsu S-M. Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer. Cancer Res 2003;63:6537-6542
13. Torng P-L, Mao T-L, Chan W-Y, Huang S-C, Lin C-T. Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression. Gynecol Oncol 2004;92:559-567
14. Kleiner DE, Stetler-Stevenson WG. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 1999;43:S42-S51.
15. Hofmann U, Eggert AAO, Blass K, Brocker E-B, Becker JC. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation. Cancer Res 2003;63:8221-8225 (Pubitemid 37549471)
16. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002;295:2387-2392 (Pubitemid 34270240)
17. American Joint Committee on Cancer, Manual for staging cancer, 3rd ed. Philadelphia: J.B. Lippincott, 1988.
18. Nichols EA, Ruddle FH. A review of enzyme polymorphism, linkage and electrophoretic conditions for mouse and somatic cell hybrids in starch gel. J Histochem 1973;21:1066-1081
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275
20. Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta L, Sawaya R. Elevated levels of Mr 92,000 type IV collagenase in human brain tumors. Cancer Res 1993;53:2208-2211 (Pubitemid 23156800)
21. Murnane MJ, Shuja S, Del Re E, Cai J, Iacobuzio-Donahue C, Klepeis V. Characterizing human colorectal carcinomas by proteolytic profile. In vivo 1997;11:209-216 (Pubitemid 27348105)
22. Itoh Y, Binner S, Nagase H. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate. Biochem J 1995;308:645-651
23. Birkedal-Hansen H, Taylor RE. Detergent-activation of latent collagenase and resolution of its component molecules. Biochem Biophys Res Commun 1982;107:1173-1178
24. Murnane MJ, Cai J, Shuja S, Cote L, Delre E, Iacobuzio-Donahue C, Kim K, Sheahan K. Changing patterns of proteolytic expression with colorectal tumor progression. In: Suzuki M, Hiwasa T, eds. Proteases Involved in Cancer. Bologna: Monduzzi Editore, 1994. 1-11.
25. Xia T, Akers K, Eisen AZ, Seltzer JL. Comparison of cleavage site specificity of gelatinases A and B using collagenous peptides. Biochim Biophys Acta 1996;1293:259-266 (Pubitemid 26122218)
26. Kolkenbrock H, Hecker-Kia A, Orgel D, Kinawi A, Ulbrich N. Progelatinase B forms from human neutrophils. Complex formation of monomer/lipocalin with TIMP-1. Biol Chem 1996;377:529-533
27. Mosteller F, Tukey JW. Data analysis and regression: a second course in statistics. Reading, MA: Addison-Wesley, 1977.
28. Cohen J. Statistical power analysis for the behavioral sciences, 2nd ed. Hillsdale NJ: Lawrence Erlbaum Associates, 1988.
29. Hedges LV, Olkin I. Statistical methods for meta-analysis. NY: Academic Press, 1985.
30. Rosner B. Fundamentals of biostatistics. Pacific Grove,CA: Duxbury, 2000. 63-65.
31. Davies B, Miles DW, Happerfield LC, Naylor MS, Bobrow LC, Rubens RD, Balkwill FR. Activity of type IV collagenases in benign and malignant breast tissue. Br J Cancer 1993;76:1126-1134
32. Waas ET, Lomme RM, Degroot J, Wobbes T, Hendriks T. Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer. Br J Cancer 2002;86:1876-1883 (Pubitemid 34888621)
33. Waas ET, Wobbes T, Lomme RM, Degroot J, Ruers T, Hendriks T. Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasis. Br J Surg 2003;90:1556-1564 (Pubitemid 37533174)
34. Yamagata S, Yoshii Y, Suh JG, Tanaka R, Shimizu S. Occurrence of an active form of gelatinase in human gastric and colorectal carcinoma tissues. Cancer lett 1991;59:51-55
35. Parsons SL, Watson SA, Collins HM, Griffin NR, Clarke PA, Steele RJ. Gelatinase (MMP-2 and 9) expression in gastrointestinal malignancy. Br J Cancer 1998;78:1495-1502.
36. Emmert-Buck MR, Roth MJ, Zhuang Z, Campo E, Rozhin J, Sloane BF, Liotta LA, Stetler-Stevenson WG. Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol 1994;145:1285-1290 (Pubitemid 24378482)
37. Liabakk N-B, Talbot I, Smith RA, Wilkinson K, Balkwill F. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type VI collagenases in colorectal cancer. Cancer Res 1996;56:190-196 (Pubitemid 26010399)
38. Zeng ZS, Cohen AM, Guillem JG. Loss of basement. membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis 1999;20:749-755
39. Papadopoulou S, Scorilas A, Arnogianaki N, Papapanayiotou B, Tzimogiani A, Agnantis N, Talieri M. Expression of gelatinase-A (MMP-2) in human colon cancer and normal colon mucosa. Tumour Biol 2001;22:383-389. (Pubitemid 34062950)
40. Yan SJ, Bloome EAG. In situ zymography: a molecular pathology technique to localize endogenous protease activity in tissue sections. Vet Pathol 2003;40:227-236
41. Hilska M, Roberts PJ, Collan YU, Laine VJ, Kössi J, Hirsimäki P, Rahkonen O, Laato M. Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer. Int J Cancer 2007;21:714-723
42. Li M, Li J-Y, Zhao A-L, He A-S, Zhou L-X, Li Y-A, Gu J. Survival stratification panel of colorectal carcinoma with combined expression of carcinoembryonic antigen, matrix metalloproteinases-2, and p27 kip1. Dis Colon Rectum 2007;50:1887-1898 (Pubitemid 350077111)
43. Tomita T, Iwata K. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas. Dis Colon Rectum 1996;39:1255-1264 (Pubitemid 26389536)
44. Mook ORF, Van Overbeek C, Ackema EG, Van Maldegem F, Frederiks WM. In situ localization of gelatinolytic activity in the extracellular matrix of metastases of colon cancer in rat. J Histochem Cytochem 2003;51:821-829
45. Kleiner DE, Stetler-Stevenson WG. Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 1994;218:325-329 (Pubitemid 24141631)
46. Maquoi E, Frankenne F, Noel A, Krell H-W, Grams F, Foidart J-M. Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells. Exp Cell Res 2000;261:348-359 (Pubitemid 32010231)
47. Hrabec E, Strek M, Nowak D, Greger J, Suwalski M, Hrabec Z. Activity of type IV collagenases (MMP-2 and MMP-9) in primary pulmonary carcinomas: a quantitative analysis. J Cancer Res Clin Oncol 2002;128:197-204. (Pubitemid 34280377)